EP3126388
Mótefni gegn EGFRVIII og notagildi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.3.2015EP published:
8.5.2019EP application number:
15712472.8
EP translation filed:
23.7.2019Grant published:
15.9.2019EPO information:
European Patent Register
Max expiry date:
9.3.2035Expiry date:
9.3.2027Next due date:
31.3.2027
Title:
ANTI-EGFRVIII ANTIBODIES AND USES THEREOF
Timeline
Today
10.3.2015EP application
8.5.2019EP Publication
23.7.2019Translation submitted
15.9.2019Registration published
9.3.2027Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, 10591-6707, Tarrytown, NY, US
Inventor
Name:
KIRSHNER, Jessica R.Address:
Tarrytown, New York, US
Name:
MACDONALD, DouglasAddress:
Tarrytown,New York, US
Name:
THURSTON, GavinAddress:
Tarrytown,New York, US
Name:
MARTIN, Joel H.Address:
Tarrytown,New York, US
Name:
DELFINO, FrankAddress:
Tarrytown,New York, US
Name:
NITTOLI, ThomasAddress:
Tarrytown,New York, US
Name:
KELLY, MarcusAddress:
Tarrytown,New York, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201461950963 PDate:
11.3.2014Country:
US
Classification
Categories:
C07K 16/28, A61K 47/50, A61K 39/395, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 18.2.2020
Expires: 9.3.2021
Payer: Patice ehf.
Number: 7
Paid: 17.2.2021
Expires: 9.3.2022
Payer: Patice ehf.
Number: 8
Paid: 17.2.2022
Expires: 9.3.2023
Payer: Patice ehf.
Number: 9
Paid: 22.2.2023
Expires: 9.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.3.2024
Expires: 9.3.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 26.2.2025
Expires: 9.3.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 9.3.2026
Expires: 9.3.2027
Payer: Árnason Faktor ehf.